Mechanisms involved in stimulation of human immunodeficiency virus type 1 replication by aminooxypentane RANTES.
about
Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitroInhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNAHIV-1 glycoprotein 41 ectodomain induces activation of the CD74 protein-mediated extracellular signal-regulated kinase/mitogen-activated protein kinase pathway to enhance viral infectionInhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5.Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C.Two mechanisms for human immunodeficiency virus type 1 inhibition by N-terminal modifications of RANTESPSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes.Oral CCR5 inhibitors: will they make it through?HIV-1 resistance to maraviroc conferred by a CD4 binding site mutation in the envelope glycoprotein gp120Use of G-protein-coupled and -uncoupled CCR5 receptors by CCR5 inhibitor-resistant and -sensitive human immunodeficiency virus type 1 variants.Multifaceted mechanisms of HIV inhibition and resistance to CCR5 inhibitors PSC-RANTES and Maraviroc.RNA viruses and the mitogenic Raf/MEK/ERK signal transduction cascade.HIV-1 Entry, Inhibitors, and ResistanceAnnulus fibrosus cells express and utilize C-C chemokine receptor 5 (CCR5) for migration.NHERF1 regulates gp120-induced internalization and signaling by CCR5, and HIV-1 production.G protein-dependent CCR5 signaling is not required for efficient infection of primary T lymphocytes and macrophages by R5 human immunodeficiency virus type 1 isolatesInhibition of human immunodeficiency virus-1 (HIV-1) by beta-chemokine analogues in mononuclear cells from HIV-1-infected patients with active tuberculosis.
P2860
Q24563937-7D9F8DEC-4CA4-4629-8692-CDD9BA9C68D1Q28478188-17A0C702-8828-40FC-BAAA-E9519924C609Q34062013-3ED74865-99AD-4EF3-8DD3-A7989011C978Q34169244-C95A04E3-AE96-4A85-9473-64F046B6C55AQ34465489-4BBB02C7-CDA9-48F8-AD46-FE47543F3A46Q34823587-F1639B8C-6F17-445B-B715-80F08B9C2E0EQ35122309-47D57D9F-4E4E-452E-AE38-F675503898ECQ36458354-07050766-33BE-489A-915E-77CEE3EE5FEBQ36559608-64070091-F825-49FB-8862-F681B8715838Q36911645-57E6FF0B-9DB4-4CF6-BF4B-30474D200EE0Q37026646-1E1F6A1F-6395-4096-B608-DD93338C2046Q37247071-096A2934-291B-4866-A6DA-E7846F49BEB5Q37945205-731CDEB0-2FC2-4E00-9269-9DEA33A143B7Q39009015-205D9A27-12E2-4E16-8B86-4C8A97D82F0FQ39452623-DF760641-CE11-4FC0-8A2B-A4B444D27132Q39700255-112AB3CD-ABAC-4F41-B754-E5547CFEA9ADQ45423213-8E848437-BC52-47AE-94B0-F8BDAD92C61A
P2860
Mechanisms involved in stimulation of human immunodeficiency virus type 1 replication by aminooxypentane RANTES.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Mechanisms involved in stimula ...... ion by aminooxypentane RANTES.
@en
Mechanisms involved in stimula ...... ion by aminooxypentane RANTES.
@nl
type
label
Mechanisms involved in stimula ...... ion by aminooxypentane RANTES.
@en
Mechanisms involved in stimula ...... ion by aminooxypentane RANTES.
@nl
prefLabel
Mechanisms involved in stimula ...... ion by aminooxypentane RANTES.
@en
Mechanisms involved in stimula ...... ion by aminooxypentane RANTES.
@nl
P2093
P2860
P1433
P1476
Mechanisms involved in stimula ...... ion by aminooxypentane RANTES.
@en
P2093
A J Marozsan
D J Templeton
M E Quiñones-Mateu
R E Offord
P2860
P304
P356
10.1128/JVI.75.18.8624-8638.2001
P407
P577
2001-09-01T00:00:00Z